arrow
M

Marco Massari

italian national institute of health
H指数:29
被引数:8,275

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Single and multiple switches, swap and retransitioning among 28,073 biological drug users with inflammatory bowel diseases: results from the Italian VALORE network

单次和多次转换、交换及重新转换在28,073例炎症性肠病生物制剂使用者中的研究:意大利VALORE网络的结果

2025-09-280
OA
Switching patterns of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database network
2024-05-214
PRE
Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021

7月19日2021年12月12日,在意大利delta变体的主要循环期间,mRNA疫苗加强剂量对 ≥ 60岁和其他高危人群的SARS-CoV-2感染和严重新型冠状病毒肺炎的有效性

2022-04-156
OA
Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study

意大利delta变体主要循环期间mRNA疫苗的有效性以及对SARS-CoV-2感染和严重新型冠状病毒肺炎的保护作用减弱: 回顾性队列研究

2022-02-1067
OAAI
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project
2021-10-1222
OAAI
Association of Influenza Vaccination and Prognosis in Patients Testing Positive to SARS-COV-2 Swab Test: A Large-Scale Italian Multi-Database Cohort Study
2021-07-0112
OAAI
Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021
2021-06-2425
OAAI
Impact of Prior Antibiotic Use in Primary Care on Escherichia coli Resistance to Third Generation Cephalosporins: A Case-Control Study

先前在初级保健中使用抗生素对大肠杆菌对第三代头孢菌素的耐药性的影响: 一项病例对照研究

2021-04-165
OAAI
Compassionate Use of Remdesivir for Patients with Severe Covid-19

对严重新型冠状病毒肺炎患者富有同情心地使用Remdesivir

2020-06-111.9K
OAAI
The impact of parallel regulatory-health technology assessment scientific advice on clinical development. Assessing the uptake of regulatory and health technology assessment recommendations

平行监管-卫生技术评估科学建议对临床发展的影响。评估对监管和卫生技术评估建议的采纳情况

2018-03-0534
OAAI